Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07460882Not ApplicableNot Yet Recruiting

The Impact of Low Sodium Salt Substitute Use on Serum Potassium Levels Among Patients With Hypertension

Role: collaborator

NCT05954884Not ApplicableUnknown

Community-based HEARTS Intervention (Pilot)

Role: lead

NCT04992039Not ApplicableCompleted

HEARTS Package Evaluation Trial in Bangladesh

Role: lead

NCT05155436Phase 4Completed

Occurrence of Dyskalemia With Treatment for Hypertension

Role: lead

All 4 trials loaded